Company Profile
GlaxoSmithKline Pharmaceuticals manufactures, distributes, and trades in pharmaceuticals in India and globally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix Respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome.
Its portfolio also includes Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease, and Seretide. Additionally, it offers general medicines, including Augmentin, an oral antibiotic for respiratory tract infections, surgical prophylaxis, dental infections, and skin infections.
Its portfolio also includes Ceftum, an anti-infective medicine, Calpol and Calpol T for pain management, Eltroxin for the treatment of hypothyroidism, Neosporin, Betnovate, T-bact, Physiogel, Tenovate, and Flutivate for dermatology indications, and CobadexCZS and CCM, which are mineral, vitamins, and nutrition products
Oncology medicines, including Jemperli and Zejula. Incorporated in 1924 and headquartered in Mumbai, India, the company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. before rebranding in 2001. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.